News & Updates
Filter by Specialty:
Long-acting ART induces viral suppression in people with HIV
People with HIV (PWH) who are treated with long-acting (LA) antiretroviral therapy (ART) achieve virologic suppression, as do those with viraemia and challenges to adherence, reports a study.
Long-acting ART induces viral suppression in people with HIV
15 Jul 2023
Patient preferences must be considered for anticoagulation duration in unprovoked VTE
Shared decision making should be practiced by clinicians to include patient preferences and values when taking into account the duration of anticoagulant therapy for unprovoked venous thromboembolism (VTE), suggests a study.
Patient preferences must be considered for anticoagulation duration in unprovoked VTE
14 Jul 2023
Ustekinumab shows efficacy in Asians with plaque psoriasis
Asian patients with moderate to severe plaque psoriasis may benefit from ustekinumab therapy, which has been shown to be both safe and effective in a Singapore study.
Ustekinumab shows efficacy in Asians with plaque psoriasis
14 Jul 2023
Fremanezumab eases migraine and depressive symptoms
Treatment with fremanezumab – an anticalcitonin gene-related peptide (CGRP) – reduces depressive symptoms in patients with migraine and comorbid major depressive disorder (MDD) in the UNITE trial.